Aclaris Therapeutics, Inc.
ACRS· Nasdaq
ACRSAclaris Therapeutics, Inc.
Filed Nov 18, 2015 · 10-Q · 49 days after period end · 0001104659-15-079966
| Metric | Q3 2015 | Q3 2014 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Net Income | -$10.63M | -$2.66M |
| EPS Diluted | -$5.12 | -$1.75 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aclaris Therapeutics, Inc. · CIK 1557746 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Nov 18, 2015 · 49 d after period end
